Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands

被引：97

作者：

Arenzana-Seisdedos, Fernando

Parmentier, Marc

机构：

[1] Inst Pasteur, INSERM, Dept Virol, Unite Pathogenie Virale Mol, F-75724 Paris, France

[2] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium

来源：

SEMINARS IN IMMUNOLOGY | 2006年 / 18卷 / 06期

关键词：

chemokine receptors; HIV co-receptors; genetic variants; CCR5; CCR2;

D O I：

10.1016/j.smim.2006.07.007

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Susceptibility to HIV infection and AIDS progression is variable among individuals and populations, and in part genetically determined. Genetic variants of genes encoding HIV co-receptors and their chemokine ligands have been described, and some of these variants were associated with resistance to HIV infection and/or disease progression. We review here the reported data regarding the variants of the CCR5, CCR2, MCRI, MIP-1 alpha/CCL3, MIP-1 beta CCL4, RANTES/CCL5 and SDF-1/CXCL12 genes. The Delta 32 deletion mutant of CCR5, resulting in a non-functional receptor not reaching the cell surface, is unambiguously associated with strong, although incomplete, resistance to HIV infection for homozygotes, and retarded progression for heterozygotes. Specific haplotypes encompassing the CCR5 and CCR2 loci, and the copy number of the CCL3L1 gene, have also been convincingly correlated with delayed progression. For other gene variants, involving CXCL12/SDF-1 and CX3CR1, conclusive evidence for their relevance in the frame of HIV susceptibility is still lacking. (C) 2006 Elsevier Ltd. All rights reserved.

引用

页码：387 / 403

页数：17

共 213 条

[71] Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitors [J].

Hartley, O ;

Gaertner, H ;

Wilken, J ;

Thompson, D ;

Fish, R ;

Ramos, A ;

Pastore, C ;

Dufour, B ;

Cerini, F ;

Melotti, A ;

Heveker, N ;

Picard, L ;

Alizon, M ;

Mosier, D ;

Kent, S ;

Offord, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (47) :16460-16465

[72] CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia [J].

He, JL ;

Chen, YZ ;

Farzan, M ;

Choe, HY ;

Ohagen, A ;

Gartner, S ;

Busciglio, J ;

Yang, XY ;

Hofmann, W ;

Newman, W ;

Mackay, CR ;

Sodroski, J ;

Gabuzda, D .

NATURE, 1997, 385 (6617) :645-649

[73] HIV-1 infection in a heterosexual man homozygous for CCR-5 Δ32 [J].

Heiken, H ;

Becker, S ;

Bastisch, I ;

Schmidt, RE .

AIDS, 1999, 13 (04) :529-530

[74] Distinctive effects of CCR5, CCR2, and SSDF1 genetic polymorphisms in AIDS progression [J].

Hendel, H ;

Hénon, N ;

Lebuanec, H ;

Lachgar, A ;

Poncelet, H ;

Caillat-Zucman, S ;

Winkler, CA ;

Smith, MW ;

Kenefic, L ;

O'Brien, S ;

Lu, W ;

Andrieu, JM ;

Zagury, D ;

Schächter, F ;

Rappaport, J ;

Zagury, JF .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 19 (04) :381-386

[75] Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease [J].

Hernandez, PA ;

Gorlin, RJ ;

Lukens, JN ;

Taniuchi, S ;

Bohinjec, J ;

Francois, F ;

Klotman, ME ;

Diaz, GA .

NATURE GENETICS, 2003, 34 (01) :70-74

[76] Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides [J].

Heveker, N ;

Montes, M ;

Germeroth, L ;

Amara, A ;

Trautmann, A ;

Alizon, M ;

Schneider-Mergener, J .

CURRENT BIOLOGY, 1998, 8 (07) :369-376

[77] Combined effect of CCR5-Δ32 heterozygosity and the CCR5 promoter polymorphism-2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission [J].

Hladik, F ;

Liu, HL ;

Speelmon, E ;

Livingston-Rosanoff, D ;

Wilson, S ;

Sakchalathorn, P ;

Hwangbo, Y ;

Greene, B ;

Zhu, TF ;

McElrath, MJ .

JOURNAL OF VIROLOGY, 2005, 79 (18) :11677-11684

[78] CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status [J].

Hoffman, TL ;

MacGregor, RR ;

Burger, H ;

Mick, R ;

Doms, RW ;

Collman, RG .

JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04) :1093-1096

[79] Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function [J].

Howard, OMZ ;

Shirakawa, AK ;

Turpin, JA ;

Maynard, A ;

Tobin, GJ ;

Carrington, M ;

Oppenheim, JJ ;

Dean, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16228-16234

[80] The role of a mutant CCR5 allele in HIV-1 transmission and disease progression [J].

Huang, YX ;

Paxton, WA ;

Wolinsky, SM ;

Neumann, AU ;

Zhang, LQ ;

He, T ;

Kang, S ;

Ceradini, D ;

Jin, ZQ ;

Yazdanbakhsh, K ;

Kunstman, K ;

Erickson, D ;

Dragon, E ;

Landau, NR ;

Phair, J ;

Ho, DD ;

Koup, RA .

NATURE MEDICINE, 1996, 2 (11) :1240-1243

← 3 4 5 6 7 8 9 10 11 12 →